Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.
The Cure Starts Now has funded $25,395,277 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 167 grants at over 100 hospitals in 29 countries.

University of Colorado Denver – $200,000
$200,000.00
November 2023
Preclinical assessment of efficacy and specificity of logic-gated CAR-T cell therapy in Diffuse Intrinsic Pontine Glioma

SIOPe DIPG/DMG Registry – $715,852 USD, € 643,014
$715,852.00
November 2023
Renewal of the European DIPG/DMG Registry

Cincinnati Children's Hospital – $200,000
$200,000.00
November 2023
Targeting diffuse midline gliomas with innovative T cell immunotherapy

Cincinnati Children's Hospital – $50,000
$50,000.00
May 2023
Exploring Novel Targets In DIPG

University Medicine Göttingen – $50,000
$50,000.00
May 2023
Starve the monster: Multi-metabolic treatment strategies for H3.3K27M-mutant DIPG/DMG

Funding of PBTCF 2023 - $25,000
$25,000.00
January 2023

University of Queensland Diamantina Institute – $100,000
$100,000.00
November 2022
Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma

Erasmus University Medical Center – $432,354
$432,354.00
November 2022
Development and optimization of targeted radiopharmaceutical therapies for pediatric brain tumors; a world-first translational study. Acronym: TARGET-FIRST

Cincinnati Children's Hospital Medical Center – $60,000
$60,000.00
November 2022
Targeting Histone Lysine Demethylases to Treat Diffuse Intrinsic Pontine Glioma

Cincinnati Children's Hospital Medical Center – $153,867
$153,867.00
November 2022
Combining innovative proton radiotherapy with targeted and immune therapies to treat DMG/DIPG

Hunter Medical Research Institute – $232,932
$232,932.00
November 2022
Enhancing the recruitment of tumor infiltrating lymphocytes to improve responses to DMG therapies

SONALASENSE – $198,436
$198,436.00
November 2022
A Phase 1/2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2 in Patients With DIPG

UPMC Childrens Hospital of Pittsburgh – $100,000
$100,000.00
November 2022
The Role of QPRT and NAD Pathways in DIPG Treatment Resistance (Continued)

The Hospital For Sick Children (SickKids) – $100,000
$100,000.00
November 2022
Synthetic lethality screening with methionine restriction for treatment of DIPG

University of Texas MD Anderson Cancer Center – $100,000
$100,000.00
November 2022
Viroimmunotherapy for pediatric brain tumors